Workflow
Hims & Hers Health: Focus On The Future, Not GLP-1s

If you'd like to learn more about how to best position yourself in under valued stocks mispriced by the market to end February, consider joining Out Fox The Street .Hims & Hers Health, Inc. (NYSE: HIMS ) reported another blockbuster quarter , yet the stock sold off again as confusion over the GLP-1 business mounts. The online health and wellness platform is now an exceptionally cheap stock with the gainsAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies m ...